In 1992, Migraine treatment changed when the first triptan was introduced to the marked. It was the Imitrex StatDose for subcutaneous injection.
This year, Migraine treatment changed again when patents expired, and the first generic triptan became available — sumatriptan, which is the triptan in the brand name Imitrex.
Now, to make aborting a Migraine fast and pain-free, the FDA has just approved the first needle-free sumatriptan injection. Made by Zogenix, it's named Sumavel, and will...
Read moreGood news for those of us who use sumatriptan (Imitrex / Imagran) injections -- Sumavel Dose-Pro is now available in the US for the acute... Read more »
Although triptans are a marked improvement over previous treatment options, many Migraineurs have not been fully satisfied with their... Read more »
One of the most common problems with Migraine medications is that oral medications are often problematic and not optimally... Read more »
Migraine disease affects close to 37 million Americans. Many Migraineurs use triptans to abort their Migraines quite successfully. For... Read more »
Our readers ask some great questions about Migraine disease and other headache disorders here on MyMigraineConnection. Nancy and I both... Read more »
One of the most common problems with Migraine medications is that oral medications are often problematic and not optimally effective. There are three... Read more »
December 28, 1992, marked a new era for Migraine sufferers with FDA approval of injectable Imitrex (sumatriptan). Imitrex was the first Migraine... Read more »
It's confusing. Some doctors tell us to take Migraine abortive medications such as the triptans early in a Migraine attack -- during the aura if... Read more »
Treating Migraines during a pregnancy has been a big problem for many women. All of the current Migraine abortives are FDA pregnancy C, which means... Read more »
Source: ADAM Encyclopedia
Headache - migraine Treatment There is no specific cure for migraine headaches. The goal is to prevent symptoms by avoiding or changing... Read more »